CD274 and cancer: The Western blot patterns of PD-L1 expression were also confirmed in immunocytochemistry, where the 22Rv1 was negative, while the DU145 and PC3 cell lines expressed PD-L1 in 20% and 30% of cancer cells, respectively (Fig. 1H).